{
  "docId": "019de076-08a6-76d8-a7d9-b68643d71f6f",
  "docSlug": "3a0354fd1e64f16191ffa0e33db132fd",
  "documentTitle": "MaxCyte | Investor Presentation Deck | 19 slides",
  "authorId": "maxcyte",
  "authorName": "MaxCyte",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 6,
  "pageCount": 19,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 1,
  "notes": "The chart shows a cumulative growth of partnerships over time from 2017 to 2023.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-08a6-76d8-a7d9-b68643d71f6f/6",
  "deckHref": "/decks/019de076-08a6-76d8-a7d9-b68643d71f6f",
  "deckJsonHref": "/decks/019de076-08a6-76d8-a7d9-b68643d71f6f.json",
  "deckAnchorHref": "/decks/019de076-08a6-76d8-a7d9-b68643d71f6f#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.68,
        "w": 0.44,
        "x": 0.51,
        "y": 0.14
      },
      "kind": "chart",
      "text": "Cumulative Potential Pre-CML Milestones",
      "attrs": null,
      "subkind": "area",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a8e24e43-79ec-41bb-9113-3e6c88b118d0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.4,
        "x": 0.08,
        "y": 0.32
      },
      "kind": "list",
      "text": "Potential value of pre-commercial (clinical development) milestones from SPLs: ~$2B\nSales-based payments upon partner's product commercialization\nRecurring revenues from lease of instruments and sales of single-use disposables that grow with program success\nMilestone revenue is MaxCyte's highest growth revenue stream",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "585e31cb-f7cf-49f6-ae31-dd549ecb520e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.35,
        "x": 0.14,
        "y": 0.18
      },
      "kind": "paragraph",
      "text": "Licensing deals include significant development milestones and high-value participation in future commercial success of partners",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c7bcc42e-36e3-4513-a9dc-815c335e6912",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.4,
        "x": 0.08,
        "y": 0.83
      },
      "kind": "source-note",
      "text": "**Casebia/CRISPR's SPL partnership (signed in 2017) included the rights to use MaxCyte's technology in the development of exa-cel (formerly known as CTX001). As announced in the press release on September 28th, 2022, Vertex has signed an SPL agreement with MaxCyte – Vertex has obtained the clinical and commercial rights to use MaxCyte's technology for the development of exa-cel (formerly known as CTX001).",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "75474508-13e0-480b-a995-a3a1f8b4e63f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.3,
        "x": 0.04,
        "y": 0.06
      },
      "kind": "title",
      "text": "Value Creation from SPLs",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d0e703a2-550c-4bfa-b69d-bb24cfa0b632",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 6,
      "from": 5,
      "beatId": "dfb91984-6b87-4a1e-a5ea-23a6ffe055b6",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Traction",
      "beatSlug": null,
      "evidence": "Slides 5-6 showcase MaxCyte's traction and value creation.",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}